Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study
Crossref DOI link: https://doi.org/10.1007/s00592-014-0623-x
Published Online: 2014-08-11
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sasso, Ferdinando Carlo
Marfella, Raffaele
Pagano, Antonio
Porta, Giovanni
Signoriello, Giuseppe
Lascar, Nadia
Minutolo, Roberto
Carbonara, Ornella
Persico, Marcello
Piscione, Federico
De Nicola, Luca
Torella, Roberto
Paolisso, Giuseppe
Text and Data Mining valid from 2014-08-11